Parasite sheds light on sleeping sickness

April 21, 2011 in Diseases, Conditions, Syndromes

Fresh insight into the survival strategy of the sleeping sickness parasite could help inform treatments for the disease.

University scientists have found that the parasite, which can transform itself into either of two physical forms, has developed a careful balance between these.

One of these types ensures infection in the bloodstream of a victim, and the other type is taken up by the tsetse fly and spread to another person or animal.

Balanced approach

The parasite maintains a trade-off between maintaining enough to beat off the and cause infection, and ensuring sufficient parasites to enable the spread of the disease.

Researchers used a combination of biological and mathematical techniques to show how the parasite balances production of each of the forms.

Their results enable fresh understanding of how the parasite reacts to its surroundings to ensure its survival in the short term as well as the long-term spread of the disease.

Millions at risk

Sleeping sickness, which is spread by the bite of the tsetse fly, affects some 30,000 people in sub-Saharan Africa. Many millions more are considered to be at risk.

The disease affects people and animals and without treatment is considered fatal.

The research, funded by the Wellcome Trust, was published in the journal .

" parasites alter their form in order to ensure their survival and spread. We hope that, having discovered more about how these parasites behave, we will be able to develop ways of interfering with their survival strategy and interrupt the spread of this disease," said Professor Keith Matthews, School of Biological Sciences.

Provided by University of Edinburgh

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

New portable tool detects dengue infected mosquitoes in the field

(Medical Xpress) -- A new portable tool to detect dengue virus-infected mosquitoes will help reduce the likelihood of human infections around the world.

Diseases, Conditions, Syndromes created 1 hour ago | popularity not rated yet | comments 0

Troublesome dyspnea during sexual activity is common in COPD patients

Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.

Diseases, Conditions, Syndromes created 1 hour ago | popularity not rated yet | comments 0

Woman with flesh-eating disease takes own breaths

(AP) -- The father of a young Georgia woman fighting a flesh-eating bacteria says his daughter is now breathing on her own.

Diseases, Conditions, Syndromes created 3 hours ago | popularity 5 / 5 (1) | comments 0

Epidemiology of rosacea described in United Kingdom

(HealthDay) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study ...

Diseases, Conditions, Syndromes created 6 hours ago | popularity not rated yet | comments 0

High prevalence of bone disease in patients referred for pulmonary rehabilitation

There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.

Diseases, Conditions, Syndromes created 18 hours ago | popularity not rated yet | comments 0


Growth factor in stem cells may spur recovery from multiple sclerosis

A substance in human mesenchymal stem cells that promotes growth appears to spur restoration of nerves and their function in rodent models of multiple sclerosis (MS), researchers at Case Western Reserve University School ...

Use of in-hospital mortality to assess ICU performance may bias quality measurement

In-hospital mortality for ICU patients is often used as a quality measure, but discharge practices may bias results in a way that disadvantages large academic hospitals, according to a recently conducted study.

Biomarker predicts response to cancer treatment

VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery ...

Heparin-like compounds inhibit breast cancer metastasis to bone

Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a ...

Stopping cell migration may help block fibrosis and the spread of cancer

(Medical Xpress) -- Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling ...

New drug shrinks brain tumours in melanoma patients

(Medical Xpress) -- Australian researchers have reported promising results with a new drug that shrinks brain tumours in melanoma patients. Their findings are published in The Lancet medical journal today. ...